Relmada Therapeutics, Inc. (RLMD)
7.345
+0.06
(+0.75%)
USD |
NASDAQ |
Apr 13, 16:00
7.345
0.00 (0.00%)
After-Hours: 16:18
Relmada Therapeutics Accounts Payable (Quarterly) : 1.569M for Dec. 31, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 11.20M |
| Theravance Biopharma, Inc. | 2.568M |
| Avalo Therapeutics, Inc. | 0.137M |
| AN2 Therapeutics, Inc. | 3.021M |
| ACADIA Pharmaceuticals, Inc. | 10.90M |